Bank of New York Mellon’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Buy |
155,881
+19,467
| +14% | +$147K | ﹤0.01% | 3038 |
|
|
2025
Q1 | $1.03M | Sell |
136,414
-1,202
| -0.9% | -$9.1K | ﹤0.01% | 3033 |
|
|
2024
Q4 | $1.68M | Sell |
137,616
-730
| -0.5% | -$8.89K | ﹤0.01% | 2827 |
|
|
2024
Q3 | $2.32M | Buy |
138,346
+349
| +0.3% | +$5.84K | ﹤0.01% | 2678 |
|
|
2024
Q2 | $2.41M | Buy |
137,997
+43,757
| +46% | +$763K | ﹤0.01% | 2692 |
|
|
2024
Q1 | $1.61M | Sell |
94,240
-4,763
| -5% | -$81.2K | ﹤0.01% | 2887 |
|
|
2023
Q4 | $1.01M | Buy |
99,003
+1,844
| +2% | +$18.8K | ﹤0.01% | 3179 |
|
|
2023
Q3 | $879K | Buy |
97,159
+9,989
| +11% | +$90.4K | ﹤0.01% | 3227 |
|
|
2023
Q2 | $938K | Sell |
87,170
-9,070
| -9% | -$97.6K | ﹤0.01% | 3221 |
|
|
2023
Q1 | $985K | Sell |
96,240
-12,771
| -12% | -$131K | ﹤0.01% | 3134 |
|
|
2022
Q4 | $1.15M | Buy |
109,011
+3,133
| +3% | +$33.1K | ﹤0.01% | 3127 |
|
|
2022
Q3 | $1.36M | Buy |
105,878
+13,574
| +15% | +$174K | ﹤0.01% | 3055 |
|
|
2022
Q2 | $1.18M | Sell |
92,304
-880
| -0.9% | -$11.3K | ﹤0.01% | 3130 |
|
|
2022
Q1 | $975K | Sell |
93,184
-2,239
| -2% | -$23.4K | ﹤0.01% | 3333 |
|
|
2021
Q4 | $1.47M | Buy |
95,423
+15,259
| +19% | +$236K | ﹤0.01% | 3164 |
|
|
2021
Q3 | $1.81M | Buy |
80,164
+40,537
| +102% | +$915K | ﹤0.01% | 3040 |
|
|
2021
Q2 | $1.02M | Buy |
39,627
+4,802
| +14% | +$124K | ﹤0.01% | 3405 |
|
|
2021
Q1 | $1.45M | Buy |
+34,825
| New | +$1.45M | ﹤0.01% | 3109 |
|